A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer
Status:
Completed
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine to what extend a treatment with the iron compounds
Iron Isomaltoside 1000 or Ferric Carboxymaltose is leading to hypophosphatemia and to study
the potential clinical impact of hypophosphatemia.